Trading a IMNM straddle lets you take a pure volatility position on Immunome Inc without committing to a direction. Immunome Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate IMNM straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on IMNM profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Immunome Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the IMNM straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the IMNM straddle is the cleanest expression of that view. Our scanner prices every IMNM straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a IMNM straddle into a catalyst or short a IMNM straddle to harvest decay, the options straddle setups that matter are all in one place.
